Why the study?
Rapid developments and growing use of transcatheter structural heart disease therapies created demands differing from routine evaluation, necessitating updated consensus on interventional imaging.
This EACVI consensus document provides updated recommendations on the use of multimodality imaging for guiding transcatheter interventions in structural heart disease.
Answers are grounded in this paper and cite their sources.
Updates imaging guidance for transcatheter aortic and mitral interventions; extends prior EACVI consensus with new access and treatment recommendations.
Transcatheter therapies for the treatment of structural heart diseases (SHD) have expanded dramatically over the last years, thanks to the developments and improvements of devices and imaging techniques, along with the increasing expertise of operators. Imaging, in particular echocardiography, is pivotal during patient selection, procedural monitoring, and follow-up. The imaging assessment of patients undergoing transcatheter interventions places demands on imagers that differ from those of the routine evaluation of patients with SHD, and there is a need for specific expertise for those working in the cath lab. In the context of the current rapid developments and growing use of SHD therapies, this document intends to update the previous consensus document and address new advancements in interventional imaging for access routes and treatment of patients with aortic stenosis and regurgitation, and mitral stenosis and regurgitation.
No takes yet. Share an insight, caveat, or question.
Agricola et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: